GC Lipid Tech utilizes genetically engineered microalgae to produce high-value marine metabolites, addressing the need for sustainable sources of energy, food, and medicine. By harnessing the unique biochemical capabilities of microalgae, the company aims to provide eco-friendly alternatives to traditional resource extraction methods.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of obtaining marine metabolites rely on unsustainable resource extraction, negatively impacting marine ecosystems. Traditional approaches often lack the scalability and eco-friendliness needed to meet growing demands for energy, food, and medicine.
Solution
GC Lipid Tech uses genetically engineered microalgae to sustainably produce high-value marine metabolites. By leveraging synthetic biology, the company offers an alternative to traditional resource extraction, providing eco-friendly solutions for energy, food, and medicine. The company's platform focuses on developing innovative tools and strains for genetically engineering microalgae to address issues surrounding the marine ecosystem. GC Lipid Tech aims to bring novel and disruptive technologies to the forefront, challenging the status quo in marine resource utilization.
Target Audience
The primary target audience includes industries seeking sustainable sources of marine metabolites for applications in energy, food, and medicine.
Features
- Genetic engineering of microalgae for enhanced production of specific marine metabolites
- Development of synthetic biology tools for strain optimization
- Sustainable production methods minimizing environmental impact
- Real-time bioreactor culture tracking (coming soon)